Standout Papers

Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive ge... 2020 2026 2022 2024250
  1. Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin (2020)
    Meijuan Li, Jason D. Hughes et al. PLoS ONE

Immediate Impact

66 standout
Sub-graph 1 of 23

Citing Papers

Non-small-cell lung cancer
2024 Standout
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
2024 Standout
2 intermediate papers

Works of Ninad Dewal being referenced

Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
2020 Standout
Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors
2019

Author Peers

Author Last Decade Papers Cites
Ninad Dewal 288 193 52 219 9 489
Abhaya Paladugu 172 100 45 214 9 423
IE Smith 227 120 31 226 9 573
Mariette Renaux‐Petel 161 81 137 248 12 562
K. Gauger 168 64 29 200 9 451
Yuichi Sameshima 197 74 61 257 9 559
Tarja Niini 91 121 35 316 15 556
Shashikant Kulkarni 139 136 66 166 8 447
Lee Lichtenstein 329 118 124 300 8 547
Julie Niolat 89 162 38 190 13 471
Amelie Lier 235 206 26 130 9 462

All Works

Loading papers...

Rankless by CCL
2026